Zena founders attend Boehringer Ingelheim 2022 Office hours

Written By Aleksi Tzatzev

Drs. Carry and Vasilatis presented their innovations and questions to the innovative minds of Boehringer Ingelheim, an insightful experience focused on regulatory pathways and navigating the drug discovery space.

Aleksi Tzatzev
Previous

Zena Tx partners with Rutgers and is awarded Catalyst R&D Voucher Program from CSIT
Next

Founding Members successfully complete NSF I-Corps Winter Hub 2022